Lineage Cell Therapeutics In shares owned by Susquehanna International
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Susquehanna International
from 13F filings
Historical chart of Susquehanna International investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Susquehanna International
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $547k | 323k | 1.69 |
| 2025-06-30 | $559k | 616k | 0.91 |
| 2025-03-31 | $107k | 236k | 0.45 |
| 2024-12-31 | $40k | 80k | 0.50 |
| 2024-09-30 | $10k | 11k | 0.91 |
| 2024-06-30 | $71k | 71k | 1.00 |
| 2024-03-31 | $52k | 35k | 1.48 |
| 2023-09-30 | $17k | 15k | 1.18 |
| 2023-06-30 | $58k | 41k | 1.41 |
| 2023-03-31 | $1.2M | 816k | 1.50 |
| 2022-12-31 | $203k | 174k | 1.17 |
| 2022-09-30 | $92k | 81k | 1.13 |
| 2022-06-30 | $274k | 172k | 1.59 |
| 2022-03-31 | $314k | 204k | 1.53 |
| 2021-12-31 | $1.2M | 498k | 2.44 |
| 2021-09-30 | $1.8M | 725k | 2.53 |
| 2021-06-30 | $852k | 299k | 2.85 |
| 2021-03-31 | $2.7M | 1.1M | 2.35 |
| 2020-12-31 | $1.1M | 607k | 1.76 |
| 2020-09-30 | $44k | 47k | 0.94 |
| 2020-06-30 | $35k | 40k | 0.87 |
| 2020-03-31 | $80k | 96k | 0.83 |
| 2019-12-31 | $53k | 59k | 0.89 |
| 2019-09-30 | $95k | 98k | 0.97 |